The First-in-Class Potassium-Competitive Acid Blocker, Vonoprazan Fumarate: Pharmacokinetic and Pharmacodynamic Considerations

Overview of attention for article published in Clinical Pharmacokinetics, September 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

blogs: 1 blog

wikipedia: 2 Wikipedia pages

Citations

dimensions_citation: 130 Dimensions

Readers on

mendeley: 85 Mendeley

Summary Blogs Wikipedia Dimensions citations

So far, Altmetric has seen 2 citations on 2 Wikipedia pages.

Vonoprazán

Cited by user FGuadarrama on 20 Jan 2023

Vonoprazán, con el nombre comercial Takecab, entre otros, es un medicamento antiácido bloqueador de los canales de potasio.

Vonoprazan

Cited by user Fvasconcellos on 29 Oct 2016

Vonoprazan fumarate is a first-in-class potassium-competitive acid blocker. It was approved in the Japanese market in February 2015.